MedPath

NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN

Neomycin and Polymyxin B Sulfates and Gramicidin Ophthalmic Solution, USP

Approved
Approval ID

9691178e-5323-40ce-a8b3-f79e88f02797

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 4, 2023

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

neomycin sulfate, polymyxin b sulfate and gramicidin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-0247
Application NumberANDA064047
Product Classification
M
Marketing Category
C73584
G
Generic Name
neomycin sulfate, polymyxin b sulfate and gramicidin
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateAugust 2, 2022
FDA Product Classification

INGREDIENTS (11)

NEOMYCIN SULFATEActive
Quantity: 1.75 mg in 1 mL
Code: 057Y626693
Classification: ACTIM
POLYMYXIN B SULFATEActive
Quantity: 10000 [USP'U] in 1 mL
Code: 19371312D4
Classification: ACTIM
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
GRAMICIDINActive
Quantity: 0.025 mg in 1 mL
Code: 5IE62321P4
Classification: ACTIB
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
POLOXAMER 188Inactive
Code: LQA7B6G8JG
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
THIMEROSALInactive
Quantity: 0.01 mg in 1 mL
Code: 2225PI3MOV
Classification: IACT
AMMONIAInactive
Code: 5138Q19F1X
Classification: IACT

Drug Labeling Information

DESCRIPTION SECTION

LOINC: 34089-3Updated: 8/2/2022

DESCRIPTION

Neomycin and polymyxin B sulfates and gramicidin ophthalmic solution, USP is a sterile antimicrobial solution for ophthalmic use.

Each mL contains: Actives: neomycin sulfate, (equivalent to 1.75 mg neomycin base), polymyxin B sulfate equal to 10,000 polymyxin B units, gramicidin, 0.025 mg;Inactives: sodium chloride, alcohol (0.5%), Poloxamer 188, propylene glycol, purified water. Hydrochloric acid and/or ammonium hydroxide may be added to adjust pH (4.7-6.0).

**Preservative:**thimerosal 0.001%.

Neomycin Sulfate is the sulfate salt of neomycin B and C, which are produced by the growth of Streptomyces fradiae Waksman (Fam. Streptomycetaceae). It has a potency equivalent of not less than 600 micrograms of neomycin base per milligram, calculated on an anhydrous basis.

The structural formulae are:

 Neomycin Sulfate (structural formula)

Polymyxin B Sulfate is the sulfate salt of polymyxin B1 and B2 which are produced by the growth of Bacillus polymyxa (Prazmowski) Migula (Fam. Bacillaceae). It has a potency of not less than 6,000 polymyxin B units per milligram, calculated on an anhydrous basis. The structural formulae are:

Polymyxin B Sulfate (structural formula)

Gramicidin (also called gramicidin D) is a mixture of three pairs of antibacterial substances (Gramicidin A, B and C) produced by the growth of Bacillus brevis Dubos (Fam. Bacillaceae). It has a potency of not less than 900 mcg of standard gramicidin per mg. The structural formulae are:

Gramicidin (structural formula)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN - FDA Drug Approval Details